This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says
BioNTech has a promising cancer treatment pipeline, per Citi.
since
auto-detected in 11 stories
57 days ago
3 months ago
found
found
4 months ago
page 1 of 1